Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,500
Closed -$1.16M 30
2022
Q3
$1.16M Sell
13,500
-50,000
-79% -$4.46M 0.66% 22
2022
Q2
$5.79M Sell
63,500
-75,000
-54% -$6.65M 3.03% 14
2022
Q1
$11.4M Buy
138,500
+5,000
+4% +$394K 5.46% 7
2021
Q4
$10.2M Hold
133,500
4.17% 12
2021
Q3
$10M Buy
+133,500
New +$10.2M 3.73% 12
2013
Q4
Sell
-520,336
Closed -$23.6M 39
2013
Q3
$23.6M Sell
520,336
-66,544
-11% -$3.04M 2.43% 22
2013
Q2
$26M Buy
+586,880
New +$26.2M 2.12% 24

Other funds holding MRK

Holowesko Partners's MRK Position: Q4 2022 in Review

Holowesko Partners sold out of Merck (MRK) in Q4 2022, closing a stake of 13,500 shares — an estimated $1.16M sold.

Holowesko Partners first reported a position in MRK in Q2 2013 and held it in 7 quarters. The position peaked at $26M in Q2 2013. 3,238 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Holowesko Partners reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Holowesko Partners sold 13,500 Merck shares in Q4 2022, an estimated $1.16M.
  • Holowesko Partners first reported a position in Merck in Q2 2013 and held it in 7 quarters.
  • Holowesko Partners's Merck position peaked at $26M in Q2 2013.
  • 3,238 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Holowesko Partners's 13F filing for Q4 2022, filed 9 Feb 2023.